Tranexamic Acid administration
PreclinicalSmall molecule
Tranexamic Acid administration is one of 7 small molecule programs targeting Femoral Neck Fracture. It is currently in Preclinical.
1
Indications
3
Total Trials
1
Active Trials
6
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
8 competitors in Femoral Neck Fracture
#DrugCompanyPhaseTrials
1Calciferol
Alnylam PharmaceuticalsApproved
Naropin
FFresenius Kabi Oncology Ltd.
Approved
Marcaine
IInnocoll
Approved
Cyklokapron
AAmring
Phase 3
Chirocaine
PPurdue Pharma LP
Preclinical
Xylocaine
MMEDRx USA, Inc.
Preclinical
Tranexamic Acid administration
KKing Chulalongkorn Memorial Hospital
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Tranexamic Acid1 trial
Tranexamic Acid Effect in Pediatric
Unknown status·—·Phase 1·NCT06097611·74 enrolled
Post Operative Pain1 trial
Postoperative Pain in Laparoscopic Radical Prostatectomy Surgery With Tranexamic Acid: Analgesia? Hiperalgesia?
Unknown status·—·Phase 4·NCT06040853·90 enrolled
Sources
References
- [1]
- [2]
- [3]
- [4]
Details